Charles River Laboratories International (CRL) Acquisitions (2009 - 2024)

Charles River Laboratories International (CRL) has reported Acquisitions for 14 consecutive years, with $5.5 million the latest figure, recorded in Q2 2024.

• In Q2 2024, Acquisitions changed N/A year-over-year to $5.5 million; the TTM figure through Sep 2025 stood at $5.5 million (down 96.35% YoY), while the FY2024 annual figure was $5.5 million, down 97.19% from the prior year.
• Acquisitions came in at $5.5 million for Q2 2024 at Charles River Laboratories International, down from $144.6 million in the prior quarter.
• The five-year high for Acquisitions was $906.3 million in Q2 2021, with the low at -$518000.0 in Q4 2020.
• Average Acquisitions over 5 years is $199.6 million, with a median of $94.2 million recorded in 2021.
• The largest YoY upside for Acquisitions was 38550.15% in 2020 against a maximum downside of 1059.26% in 2020.
• Year by year, Acquisitions stood at -$518000.0 in 2020, then soared by 293.44% to $1.0 million in 2021, then surged by 28182.63% to $283.4 million in 2022, then sank by 48.97% to $144.6 million in 2023, then slumped by 96.21% to $5.5 million in 2024.
• According to Business Quant data, Acquisitions over the past three periods registered $5.5 million, $144.6 million, and $50.2 million for Q2 2024, Q4 2023, and Q2 2023 respectively.